[Radiologic Evaluation for Resectability of Pancreatic Adenocarcinoma]

Overview

Journal Taehan Yongsang Uihakhoe Chi

Specialty Radiology

Date 2022 Oct 14

PMID 36238739

Authors

Shin Hye Hwang

Mi-Suk Park

Affiliations

Soon will be listed here.

Abstract

Imaging studies play an important role in the detection, diagnosis, assessment of resectability, staging, and determination of patient-tailored treatment options for pancreatic adenocarcinoma. Recently, for patients diagnosed with borderline resectable or locally advanced pancreatic cancers, it is recommended to consider curative-intent surgery following neoadjuvant or palliative therapy, if possible. This review covers how to interpret imaging tests and what to consider when assessing resectability, diagnosing distant metastasis, and re-assessing the resectability of pancreatic cancer after neoadjuvant or palliative therapy.

References

Muller M, Meyenberger C, Bertschinger P, Schaer R, Marincek B . Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology. 1994; 190(3):745-51. DOI: 10.1148/radiology.190.3.8115622. View

OReilly D, Fou L, Hasler E, Hawkins J, OConnell S, Pelone F . Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence. Pancreatology. 2018; 18(8):962-970. DOI: 10.1016/j.pan.2018.09.012. View

Giovinazzo F, Turri G, Katz M, Heaton N, Ahmed I . Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Br J Surg. 2015; 103(3):179-91. DOI: 10.1002/bjs.9969. View

Loizou L, Duran C, Axelsson E, Andersson M, Keussen I, Strinnholm J . Radiological assessment of local resectability status in patients with pancreatic cancer: Interreader agreement and reader performance in two different classification systems. Eur J Radiol. 2018; 106:69-76. DOI: 10.1016/j.ejrad.2018.06.014. View

Chang S, Nguyen D, Raptis C, Menias C, Zhou G, Wang-Gillam A . Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: a retrospective cohort study. Ann Surg. 2014; 261(5):970-5. DOI: 10.1097/SLA.0000000000000719. View

Varadhachary G, Tamm E, Abbruzzese J, Xiong H, Crane C, Wang H . Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006; 13(8):1035-46. DOI: 10.1245/ASO.2006.08.011. View

Pappas S, Christians K, Tolat P, Mautz A, Lal A, McElroy L . Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?. HPB (Oxford). 2013; 16(1):70-4. PMC: 3892317. DOI: 10.1111/hpb.12074. View

Yamamoto T, Satoi S, Kawai M, Motoi F, Sho M, Uemura K . Is distal pancreatectomy with en-bloc celiac axis resection effective for patients with locally advanced pancreatic ductal adenocarcinoma? -Multicenter surgical group study. Pancreatology. 2017; 18(1):106-113. DOI: 10.1016/j.pan.2017.11.005. View

Naumann P, Ottensmeier F, Farnia B, Ben-Josef E, Liermann J, Maier-Hein K . Radiographic Response of Vessel Involvement and Resectability After Neoadjuvant Chemoradiation in Patients With Locally Advanced Pancreatic Cancer. Am J Clin Oncol. 2020; 43(11):776-783. DOI: 10.1097/COC.0000000000000746. View

10.

Jeon S, Lee J, Joo I, Lee D, Ahn S, Woo H . Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. Eur Radiol. 2018; 28(8):3484-3493. DOI: 10.1007/s00330-017-5258-1. View

11.

Michelakos T, Pergolini I, Fernandez-Del Castillo C, Honselmann K, Cai L, Deshpande V . Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX. Ann Surg. 2017; 269(4):733-740. DOI: 10.1097/SLA.0000000000002600. View

12.

Kim B, Kim J, Ahn S, Joo I, Choi S, Park S . CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis. Eur Radiol. 2018; 29(1):362-372. DOI: 10.1007/s00330-018-5574-0. View

13.

Yamamoto Y, Sakamoto Y, Ban D, Shimada K, Esaki M, Nara S . Is celiac axis resection justified for T4 pancreatic body cancer?. Surgery. 2011; 151(1):61-9. DOI: 10.1016/j.surg.2011.06.030. View

14.

Cassinotto C, Mouries A, Lafourcade J, Terrebonne E, Belleannee G, Blanc J . Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy. Radiology. 2014; 273(1):108-16. DOI: 10.1148/radiol.14132914. View

15.

Gonzalo-Marin J, Vila J, Perez-Miranda M . Role of endoscopic ultrasound in the diagnosis of pancreatic cancer. World J Gastrointest Oncol. 2014; 6(9):360-8. PMC: 4163734. DOI: 10.4251/wjgo.v6.i9.360. View

16.

Neuzillet C, Gaujoux S, Williet N, Bachet J, Bauguion L, Colson Durand L . Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC). Dig Liver Dis. 2018; 50(12):1257-1271. DOI: 10.1016/j.dld.2018.08.008. View

17.

Katz M, Marsh R, Herman J, Shi Q, Collison E, Venook A . Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol. 2013; 20(8):2787-95. PMC: 5600517. DOI: 10.1245/s10434-013-2886-9. View

18.

Bipat S, Phoa S, van Delden O, Bossuyt P, Gouma D, Lameris J . Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr. 2005; 29(4):438-45. DOI: 10.1097/01.rct.0000164513.23407.b3. View

19.

Delpero J, Sauvanet A . Vascular Resection for Pancreatic Cancer: 2019 French Recommendations Based on a Literature Review From 2008 to 6-2019. Front Oncol. 2020; 10:40. PMC: 7010716. DOI: 10.3389/fonc.2020.00040. View

20.

Kalimuthu S, Serra S, Dhani N, Chetty R . The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes. J Clin Pathol. 2016; 69(6):463-71. DOI: 10.1136/jclinpath-2016-203604. View